99 related articles for article (PubMed ID: 7692621)
21. Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats.
Di Marco R; Zaccone P; Magro G; Grasso S; Lunetta M; Barcellini W; Nicolosi VM; Meroni PL; Nicoletti F
Clin Exp Immunol; 1996 Aug; 105(2):338-43. PubMed ID: 8706343
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha.
Satoh J; Seino H; Shintani S; Tanaka S; Ohteki T; Masuda T; Nobunaga T; Toyota T
J Immunol; 1990 Sep; 145(5):1395-9. PubMed ID: 2384663
[TBL] [Abstract][Full Text] [Related]
23. Effects of cyclosporin A and insulin on peripheral lymphocytes in BB/W rats.
Suzuki M; Kawazu S; Negishi K; Shunto S; Takahashi M; Watanabe T; Katayama S; Ushi J; Komeda K
Diabetes Res; 1988 Jul; 8(3):123-8. PubMed ID: 3067953
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
Saudek F; Malaise J; Boucek P; Adamec M;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
[TBL] [Abstract][Full Text] [Related]
25. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine.
Arai S; Teramoto S; Senoo Y
J Heart Lung Transplant; 1992; 11(4 Pt 1):757-62. PubMed ID: 1379829
[TBL] [Abstract][Full Text] [Related]
26. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus.
Rodríguez-Rodríguez AE; Triñanes J; Porrini E; Velázquez-García S; Fumero C; Vega-Prieto MJ; Díez-Fuentes ML; Luis Lima S; Salido E; Torres A
Nefrologia; 2015; 35(3):264-72. PubMed ID: 26299169
[TBL] [Abstract][Full Text] [Related]
27. Prevention of adoptive transfer in BB rats by prophylactic insulin treatment.
Bertrand S; De Paepe M; Vigeant C; Yale JF
Diabetes; 1992 Oct; 41(10):1273-7. PubMed ID: 1397700
[TBL] [Abstract][Full Text] [Related]
28. The role of testosterone in cyclosporine-induced osteopenia.
Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
[TBL] [Abstract][Full Text] [Related]
29. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density.
Hehmke B; Lucke S; Schröder D; Klöting I; Kohnert KD
Eur J Immunol; 1990 May; 20(5):1091-6. PubMed ID: 2192902
[TBL] [Abstract][Full Text] [Related]
30. Calcineurin inhibitors in renal transplantation: what is the best option?
Tanabe K
Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin prevents diabetes in BB Wistar rats.
Laupacis A; Stiller CR; Gardell C; Keown P; Dupre J; Wallace AC; Thibert P
Lancet; 1983 Jan; 1(8314-5):10-2. PubMed ID: 6129365
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of diabetes mellitus induced with FK506 in SD rats models.
Li QY; Li F; Sun JH; Chi YY; Yin HS; Liu SQ; Mei YH
Immunopharmacol Immunotoxicol; 2009; 31(4):675-81. PubMed ID: 19874240
[TBL] [Abstract][Full Text] [Related]
33. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model.
McElwee KJ; Rushton DH; Trachy R; Oliver RF
Br J Dermatol; 1997 Oct; 137(4):491-7. PubMed ID: 9390322
[TBL] [Abstract][Full Text] [Related]
34. Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506.
Bavandi A; Meingassner JG; Becker S
Exp Dermatol; 1992 Nov; 1(4):199-205. PubMed ID: 1285411
[TBL] [Abstract][Full Text] [Related]
35. Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone.
Kiesel U; Maruta K; Treichel U; Bicker U; Kolb H
J Immunopharmacol; 1986; 8(3):393-406. PubMed ID: 3760592
[TBL] [Abstract][Full Text] [Related]
36. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
[TBL] [Abstract][Full Text] [Related]
37. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
Schwaninger M; Blume R; Oetjen E; Knepel W
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
[TBL] [Abstract][Full Text] [Related]
38. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion.
Woo J; Propper DJ; Macleod AM; Thomson AW
Clin Exp Immunol; 1990 Dec; 82(3):462-8. PubMed ID: 1702375
[TBL] [Abstract][Full Text] [Related]
39. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
40. [An experimental study of spontaneously diabetic Bio Breeding/Worcester (BB/W) rats--with special references to the rat MHC (RT1) in the development of the disease].
Misonou J
Hokkaido Igaku Zasshi; 1989 May; 64(3):349-62. PubMed ID: 2570014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
